logo

For the Inventor, By the Inventor

Wilrijk, Belgium

Frederik Jan Rita Rombouts

This inventor holds 14 USPTO granted patents and 13 published patent applications and 15 EPO patents. Top assignees: Janssen Pharmaceutica Nv, Cellzome Limited, Janssen Pharmaceuticals, Inc.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederik Jan Rita Rombouts. Retrieved from https://idiyas.com/inventor/frederik-jan-rita-rombouts

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 78.6

 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Antwerpen, BE (2013 - 2015)
  • Antwerp, BE (2012 - 2016)
  • Beerse, BE (2017 - 2020)
  • Wilrijk, BE (2015 - 2024)

Company Filing History:

goldMedal12 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal2 out of 21 
 
Cellzome Limited
 patents
bronzeMedal2 out of 161 
 
Janssen Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2012-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 12006302 - Tau PET imaging ligands (2024-06-11),
2. 11168068 - Tau PET imaging ligands (2021-11-09),
3. 10604523 - 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives (2020-03-31),
4. 10562897 - Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators (2020-02-18),
5. 10246454 - Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators (2019-04-02),
6. 10112943 - Substituted imidazoles as gamma secretase modulators (2018-10-30),
7. 9828350 - 5,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE) (2017-11-28),
8. 9273013 - Quinazoline derivatives (2016-03-01),
9. 9181245 - Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease (2015-11-10),
10. 8946266 - Substituted triazole and imidazole derivatives as gamma secretase modulators (2015-02-03),
11. 8778919 - Cyclic anilino—pyridinotriazines (2014-07-15),
12. 8394955 - 2,4 (4,6) pyrimidine derivatives (2013-03-12),
13. 8394786 - Quinazoline derivatives (2013-03-12),
14. 8148388 - 2,4 (4,6) pyrimidine derivatives (2012-04-03),

Title: The Innovative Mind of Frederik Jan Rita Rombouts

Introduction: Frederik Jan Rita Rombouts, a talented inventor hailing from Wilrijk, Belgium, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Frederik Jan Rita Rombouts has recently been granted several patents for his cutting-edge inventions in the realm of artificial intelligence and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Frederik Jan Rita Rombouts has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has revolutionized various industries, earning him recognition as a pioneer in his field.

Collaborations: Throughout his career, Frederik Jan Rita Rombouts has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Frederik Jan Rita Rombouts continues to push the boundaries of innovation, with his relentless pursuit of excellence and passion for creating technologies that have a positive impact on society. His contributions to the world of inventions are truly remarkable, and his legacy is sure to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…